focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,789.00
Bid: 1,789.00
Ask: 1,789.50
Change: -23.50 (-1.30%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,785.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks dip despite barrage of positive readings on the economy

Fri, 23rd Apr 2021 12:04

(Sharecast News) - Stocks are holding lower at the end of the week despite very positive news out on the UK economy, after Bloomberg reported that Democrats on Capitol Hill want to double the US capital gains tax to nearly 39.6%.
"European markets are on the back foot in early trade, with valuations taking a dive in the wake of Joe Biden's proposal to implement a near 50% stamp duty rate on high earners. With the past year having seen traders react with glee over repeated bouts of stimulus, traders are gradually seeing the uncomfortable truth that those debts have to be paid one way or another," said Josh Mahony, senior market analyst at IG.

"Quite whether Biden manages to garner enough support to pass this bill remains to be seen, with the president likely to require almost unanimous support from the Democrats given the expected widespread rejection from the GOP."

Another key consideration according to experts was whether any tax hikes would be applied retroactively to 2021.

Against that backdrop, as of 1205 BST the FTSE 100 was trading lower by 0.48% or 33.12 points to 6,905.04, while the second-tier index was down by 0.22% or 49.39 points at 22,315.48.

Futures tracking the S&P 500 on the other hand were now bouncing back by 11.5 points to 4,139.25.

Sterling was higher alongside too, adding 0.33% to 1.3885.

Barrage of positive economic data

The news on the economic front nevertheless was surprisingly positive.

According to the Office for National Statistics, UK retail sales surged at a month-on-month pace of 5.4% in March (consensus: 1.5%).

That was despite non-essential stores having remained shut until 12 April.

IHS Markit's Purchasing Managers Indices for factory and services also came in ahead of forecasts for April, with record levels of optimism for the year ahead "setting the scene for a bumper second quarter for the economy".

Consultancy GfK meanwhile reported an improvement in its UK consumer confidence index from -16 for March to -15 in April, although shoppers appeared to be returning "quite tentatively" to stores, said Samuel Tombs at Pantheon Macroeconomics.

Public sector net borrowing data for March also came in better than expected, at £28.0bn (consensus: £22.0bn), for total 2020/21 fiscal year borrowing £303.1bn or 14.5% of GDP, the most since WWII, but in any case than the OBR's projection for £354.6bn in the March budget.

First Group sells US assets to lower debt pile

FirstGroup has agreed to sell its First Student and First Transit US bus businesses to EQT Infrastructure for an enterprise value of £3.3bn. The UK transport group said it would use £2.19bn of initial net proceeds to cut debt, pay into its pension schemes and return £365m, or 30p a share, to shareholders during 2021.

GlaxoSmithKline said the US Food and Drug Administration (FDA) has approved 'Jemperli', or dostarlimab-gxly, based on its Biologics License Application. The AIM-traded firm said dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody, is indicated for the treatment of adult patients with mismatch repair-deficient recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that have progressed on or following prior treatment with a platinum-containing regimen. It said the indication was given accelerated approval based on tumour response rate and durability of response.

LondonMetric Property has sold two long income assets let to Marks & Spencer and Wickes in Derby for a combined £11.1m to unnamed buyers. The sale represents a blended net initial yield of 6% and a 7% surplus to the last reported book value. One property is a M&S Foodhall, sold by way of a forward commitment to an overseas private investor for £6.2m and the other a Wickes store, sold to an overseas property company for £4.9m.

Market Movers

FTSE 100 (UKX) 6,908.47 -0.43%
FTSE 250 (MCX) 22,309.18 -0.25%
techMARK (TASX) 4,346.48 -0.39%

FTSE 100 - Risers

Intertek Group (ITRK) 6,252.00p 1.86%
Taylor Wimpey (TW.) 187.55p 1.49%
Evraz (EVR) 639.40p 1.46%
Just Eat Takeaway.Com N.V. (CDI) (JET) 7,956.00p 1.26%
Glencore (GLEN) 295.90p 1.16%
Flutter Entertainment (CDI) (FLTR) 15,075.00p 1.14%
Smith (DS) (SMDS) 417.10p 0.97%
Anglo American (AAL) 3,119.50p 0.82%
InterContinental Hotels Group (IHG) 5,148.00p 0.82%
WPP (WPP) 960.00p 0.80%

FTSE 100 - Fallers

International Consolidated Airlines Group SA (CDI) (IAG) 196.08p -2.20%
Next (NXT) 7,880.00p -2.11%
Hargreaves Lansdown (HL.) 1,667.50p -1.74%
Diageo (DGE) 3,260.00p -1.70%
Hikma Pharmaceuticals (HIK) 2,396.00p -1.68%
Reckitt Benckiser Group (RKT) 6,691.00p -1.62%
Smith & Nephew (SN.) 1,470.00p -1.47%
United Utilities Group (UU.) 953.40p -1.47%
Sainsbury (J) (SBRY) 245.30p -1.37%
Auto Trader Group (AUTO) 569.00p -1.35%

FTSE 250 - Risers

FirstGroup (FGP) 92.55p 8.75%
SSP Group (SSPG) 337.90p 2.83%
Network International Holdings (NETW) 430.00p 2.38%
National Express Group (NEX) 324.00p 2.02%
Crest Nicholson Holdings (CRST) 415.80p 2.01%
Fidelity China Special Situations (FCSS) 438.00p 1.86%
Mitchells & Butlers (MAB) 310.80p 1.83%
Restaurant Group (RTN) 124.80p 1.79%
Vistry Group (VTY) 1,232.00p 1.73%
XP Power Ltd. (DI) (XPP) 5,230.00p 1.55%

FTSE 250 - Fallers

Workspace Group (WKP) 801.50p -4.13%
AO World (AO.) 285.80p -3.18%
AJ Bell (AJB) 437.00p -2.85%
Capita (CPI) 42.73p -2.67%
easyJet (EZJ) 984.80p -2.64%
Beazley (BEZ) 328.30p -2.55%
Carnival (CCL) 1,637.20p -2.28%
CMC Markets (CMCX) 491.00p -2.00%
IWG (IWG) 349.90p -1.85%
Allianz Technology Trust (ATT) 2,940.00p -1.84%
More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.